Track topics on Twitter Track topics that are important to you
This unique sevencountry report, 1,398page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.nbsp;
Business and technological trends in seven major markets
Five and tenyear test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Profiles of market players and startup firms developing innovative technologies
nbsp;nbsp; and products
Specific product and business opportunities for instrument and consumable suppliers.
The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of costeffective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.
Worldwide Market Overview
Laboratories performing DNA sequencing andnbsp; NAT
by country and market segment.
Fiveyear test volume and sales projections by country.
Market Segmentation Analysis
Sales and market shares of major suppliers of NAT
reagent kits and components.
Tenyear test volume and sales forecasts for major
Infectious Diseasesnbsp;nbsp;nbsp;nbsp; Forensic Testing
Cancernbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Paternity Testing/HLA Typing
Genetic Diseasesnbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Others
Tenyear test volume and sales projections for over 30
A comprehensive analysis of the sequencing market,
by country and laboratory segment, including:
Detailed market segmentation analysis, including
review of the market dynamics, trends, structure, size,
growth and major suppliers, by country.
Comparison of leading NAT
analyzers from Abbott, Beckman Coulter, BD, BioRad,
GenProbe, Roche, Tecan and other suppliers.
Extensive review of NAT technologies,
test formats, detection methodologies, trends
in testing automation and over 30 target/signal
amplification methods, including:
TMAnbsp;nbsp;nbsp; SSSR, and others
Worldwide listings of companies, universities and
research centers developing new NAT
technologies and products.
Extensive strategic assessments
of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing
tactics, collaborative arrangements and new technologies/products
Comprehensive listings of companies developing and
marketing NAT products, by test and
Opportunities and Strategic Recommendations
Specific new product development opportunities
with potentially significant market appeal during
the next ten years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.
This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and startup firms developing innovative technologies and products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchrsquo;s proprietary data base was conducted.
Contains 1,398 pages and 194 tables
Original Article: Global Nucleic Acid Testing/NAT Market 2021: US, Europe, JapanSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Prices from USD $345NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...